CA2297133A1 - Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor - Google Patents

Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor Download PDF

Info

Publication number
CA2297133A1
CA2297133A1 CA002297133A CA2297133A CA2297133A1 CA 2297133 A1 CA2297133 A1 CA 2297133A1 CA 002297133 A CA002297133 A CA 002297133A CA 2297133 A CA2297133 A CA 2297133A CA 2297133 A1 CA2297133 A1 CA 2297133A1
Authority
CA
Canada
Prior art keywords
compound
insulin
administration
pharmaceutically acceptable
dione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002297133A
Other languages
English (en)
French (fr)
Inventor
Stephen Alistair Smith
Robin Edwin Buckingham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2297133A1 publication Critical patent/CA2297133A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
CA002297133A 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor Abandoned CA2297133A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
GB9715298.7 1997-07-18
PCT/GB1998/002112 WO1999003478A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor

Publications (1)

Publication Number Publication Date
CA2297133A1 true CA2297133A1 (en) 1999-01-28

Family

ID=10816170

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002297133A Abandoned CA2297133A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor

Country Status (27)

Country Link
EP (1) EP1001784A1 (sk)
JP (1) JP2001510160A (sk)
KR (1) KR20010021952A (sk)
CN (1) CN1263467A (sk)
AP (1) AP2000001735A0 (sk)
AR (2) AR016350A1 (sk)
AU (1) AU8449098A (sk)
BG (1) BG104062A (sk)
BR (1) BR9810292A (sk)
CA (1) CA2297133A1 (sk)
CO (1) CO4940489A1 (sk)
DZ (1) DZ2563A1 (sk)
EA (1) EA200000140A1 (sk)
GB (1) GB9715298D0 (sk)
HU (1) HUP0003626A3 (sk)
ID (1) ID23804A (sk)
IL (1) IL133907A0 (sk)
MA (1) MA24608A1 (sk)
NO (1) NO20000230D0 (sk)
OA (1) OA11312A (sk)
PE (1) PE99499A1 (sk)
PL (1) PL338140A1 (sk)
SK (1) SK612000A3 (sk)
TR (1) TR200000133T2 (sk)
UY (1) UY25101A1 (sk)
WO (1) WO1999003478A1 (sk)
ZA (1) ZA986364B (sk)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
PT1133312E (pt) 1999-06-21 2007-11-30 Lilly Co Eli Uso sinergístico de tiazolidinodionas com péptido 1 semelhante ao glucagon e os seus agonistas para tratar diabetes não insulino-dependente
DE122008000018I1 (de) * 2000-01-21 2008-08-14 Novartis Pharma Ag Zusammensetzungen bestehend aus Dipeptidylpeptidase-IV Inhibitoren und Antidiabetica
WO2001062295A1 (fr) * 2000-02-24 2001-08-30 Takeda Chemical Industries, Ltd. Medicaments contenant des ingredients actifs combines
JP4917712B2 (ja) * 2000-02-24 2012-04-18 武田薬品工業株式会社 併用医薬
EP1738751B1 (en) 2001-01-12 2011-05-11 Sun Pharma Advanced Research Company Ltd Spaced drug delivery system
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
AU2004285354B2 (en) 2003-10-31 2009-09-17 Takeda Pharmaceutical Company Limited Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
CN101103993B (zh) * 2006-07-14 2011-03-30 北京华安佛医药研究中心有限公司 降糖药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE151634T1 (de) * 1991-08-26 1997-05-15 Upjohn Co Flüssiges nahrungsmittel, das 3- guanidinopropionsäure enthält
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
EA200000140A1 (ru) 2000-06-26
UY25101A1 (es) 2000-12-29
AR019724A2 (es) 2002-03-13
CN1263467A (zh) 2000-08-16
NO20000230L (no) 2000-01-17
PE99499A1 (es) 1999-12-18
BR9810292A (pt) 2000-09-19
TR200000133T2 (tr) 2000-09-21
HUP0003626A3 (en) 2001-12-28
NO20000230D0 (no) 2000-01-17
CO4940489A1 (es) 2000-07-24
BG104062A (en) 2000-11-30
WO1999003478A1 (en) 1999-01-28
ID23804A (id) 2000-05-11
KR20010021952A (ko) 2001-03-15
GB9715298D0 (en) 1997-09-24
HUP0003626A2 (hu) 2001-05-28
ZA986364B (en) 2000-01-17
MA24608A1 (fr) 1999-04-01
AP2000001735A0 (en) 2000-01-16
AU8449098A (en) 1999-02-10
SK612000A3 (en) 2000-07-11
PL338140A1 (en) 2000-09-25
DZ2563A1 (fr) 2003-02-15
IL133907A0 (en) 2001-04-30
EP1001784A1 (en) 2000-05-24
JP2001510160A (ja) 2001-07-31
OA11312A (en) 2003-10-24
AR016350A1 (es) 2001-07-04

Similar Documents

Publication Publication Date Title
US20070004780A1 (en) Treatment of Diabetes with Thiazolidinedione and Metformin
US20030109553A1 (en) Treatment of diabetes with thiazolidinedione and metformin
US20080058388A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
EP1001783B1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
CA2297133A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
AU743269B2 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
CA2294134A1 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
US20040122060A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
AU8539298A (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
US20030109561A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
US20030092750A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
US20010034356A1 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
AU2928002A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
MXPA00000655A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
AU1540002A (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
AU2005227371A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
MXPA00000633A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
MXPA99012098A (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor

Legal Events

Date Code Title Description
FZDE Discontinued